Cardiovascular diseases, including acute myocardial infarction, stroke, peripheral arterial
diseases, and pulmonary embolism, are the most common and growing cause of morbidity …

Purpose To test the hypothesis that a mixture combining fast and slower release rate
microspheres can restore blood flow rapidly and prevent formation of another blockage in …

Dextrans show great promise for delivery of therapeutic agents. Dextran acetates (DAs)
were synthesized with increasing degrees of substitution (DA1< DA2< DA3) by the reaction …

US20230330031A1 - Particles for Targeted Delivery and Uses in Managing Bleeding or Blood
Clotting - Google Patents US20230330031A1 - Particles for Targeted Delivery and Uses in …

Thrombosis or embolism is the leading cause of death and long-term adult disability
worldwide. To reduce the risk of thrombosis and hemorrhaging in patients, a facile and …

Methods: PEG microcapsules containing SK were prepared by the method of double
emulsification, using an ultrasonic device and polyvinyl alcohol as emulsifying agent. To …

A product, composition, suspension and/or method to treat subjects infected with respiratory
viruses, such as coronavirus, and in relieving hypoxic condition. A suspension of …

The development of thrombolytic drug carriers capable of thrombus-targeting, prolonged
circulation time, intelligent responsive release, and the ability to inhibit thrombotic …

In this study, we describe the synthesis of an amine-modified acetalated dextran polymer,
which is combined with heparin (HP) as the basis for a novel controlled release system …

This disclosure relates to microcapsule particles for targeted delivery of drugs. In certain
embodiments, the particles comprise polyelectrolyte polymers, eg, layers of anionic …